BioM AG Munich BioTech Development
Overview
BioM is the network and cluster management organization for the biotechnology sector in Munich and Bavaria, commissioned by the Bavarian Ministry of Economic Affairs. It provides support, coaching, and seed financing to early-stage biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fusix Biotech | Jul 2022 | Pre Seed | Co-investor |
| MSAID GmbH | Oct 2021 | Grant | Co-investor |
| Nanion Technologies | Jan 2002 | Seed | Co-investor |
| advanceCOR | Aug 2015 | VC Round | Co-investor |
| RNATICS | Jun 2024 | Accelerator | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioM AG Munich BioTech Development based?
BioM AG Munich BioTech Development is headquartered in Germany.
When was BioM AG Munich BioTech Development founded?
BioM AG Munich BioTech Development was founded in 1997.
How many portfolio companies does BioM AG Munich BioTech Development have?
BioM AG Munich BioTech Development has 5 portfolio companies in Caplight's dataset.
What are some companies in BioM AG Munich BioTech Development's portfolio?
Portfolio companies visible on Caplight include Fusix Biotech, MSAID GmbH, Nanion Technologies, advanceCOR, RNATICS.
What was BioM AG Munich BioTech Development's most recent investment shown here?
BioM AG Munich BioTech Development's most recent investment in this portfolio sample was in RNATICS in 2024.
What sectors does BioM AG Munich BioTech Development focus on?
BioM AG Munich BioTech Development focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does BioM AG Munich BioTech Development focus on?
Stage focus information for BioM AG Munich BioTech Development is not publicly available.